Michael Ingargiola, MD
Plastic and Reconstructive Surgery · Pearl River, NYNPI 1306264528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 74.9% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $726, more than ten times the $11 reported in 2020.
Across 53 payments — averaging $42.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Motiva USA, LLC$284
- Galderma Laboratories, L.p.$110
- Sientra, Inc.$104
- Davol Inc.$26
- Integra Lifesciences Corporation$25
- plus $15 from 1 others
What the payments were for
- Food & beverage$2,246100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $1,681 |
| Motiva USA, LLC | 6 | $284 |
| Galderma Laboratories, L.p. | 6 | $110 |
| Sientra, Inc. | 3 | $104 |
| Davol Inc. | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $25 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,246 in reported general payments places this provider in the 55th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Pearl River
- Thomas DavenportGarden City$2.8M
- Howard LangsteinRochester$350K
- James BradleyNew Hyde Park$306K
- David FuntWoodmere$295K
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Tara HustonStony Brook$95K
- Theodore DiktabanNew York$83K
- Jeffrey RidhaSaratoga Springs$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.